CEO: Dr. Bobby Reddy, Jr
Dr. Reddy has 10 years of research experience in the biosensor device space. He has a PhD in Electrical Engineering from UIUC, focusing on electrical point of care diagnostic devices. He has authored or co-authored over 25 journal publications and has overseen several strategic partnerships involving postdoctoral researchers, graduate students, and working research professionals for electrical biosensor development with companies and universities such as Taiwan Semiconductor Manufacturing Company, Abbott Diagnostics, Intel Corporation, Indiana University School of Medicine, and Purdue University.
Chief Scientist: Dr. Rashid Bashir
Rashid Bashir is the Abel Bliss Professor of Bioengineering and Department Head and was previously the Director of the Micro and Nanotechnology Laboratory at UIUC. He has authored or co-authored over 150 journal papers, over 200 conference papers and conference abstracts, and over 120 invited talks, and has been granted 34 patents. He has also been involved in 2 startups that licensed technologies out of his research group, including Daktari Diagnostics, which has successfully raised over $30 million in funding.
Business Development: Gary Durack
Gary Durack is an electrical engineer with over 37 years of experience in the design and application of IVD and RUO cell measurement and sorting devices and a highly successful technology entrepreneur. His career includes 10 years with the Coulter Corporation, where he participated in all aspects of the hematology and flow cytometry business, followed by 11 years with Purdue University and the University of Illinois, where he built successful cell analysis core laboratory facilities. In 2001, Gary leveraged IP developed through his cytometry consulting business to launch the first of three companies that eventually became iCyt Visionary Bioscience. This company designed, manufactured, and sold highly advanced cell sorters for research and industrial use, benchtop cytometry analyzers, and a complete line of reagents. In 2009, the Sony Corporation acquired iCyt as their first acquisition in the life science space. He remained CEO of the Sony subsidiary until 2012, expanding distribution and service operations in North America, Europe, and Asia.